Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Study Comparing a 13-valent Pneumococcal Conjugate Vaccine With 23-valent Pneumococcal Polysaccharide Vaccine in Adults

ClinicalTrials.gov ID: NCT00427895

Public ClinicalTrials.gov record NCT00427895. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 7:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Active-controlled, Modified Double-blind Trial Evaluating The Safety, Tolerability, And Immunogenicity Of A 13-valent Pneumococcal Conjugate Vaccine (13vpnc) Compared To A 23-valent Pneumococcal Polysaccharide Vaccine (23vps) In Adults 60 To 64 Years Old Who Are Naive To 23vps And The Safety, Tolerability, And Immunogenicity Of 13vpnc In Adults 18-59 Years Old Who Are Naïve To 23vps

Study identification

NCT ID
NCT00427895
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
2,141 participants

Conditions and interventions

Interventions

  • 13-valent pneumococcal conjugate vaccine (13vPnC) Biological
  • 23-valent Pneumococcal Polysaccharide Vaccine (23vPS) Biological

Biological

Eligibility (public fields only)

Age range
18 Years to 64 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 26, 2007
Primary completion
Jul 31, 2011
Completion
Jul 31, 2011
Last update posted
Nov 14, 2021

2007 – 2011

United States locations

U.S. sites
26
U.S. states
16
U.S. cities
22
Facility City State ZIP Site status
Accelovance Huntsville Alabama 35802
East Valley Family Physicians, PLC Chandler Arizona 85224
Clinical Research Advantage/Central Phoenix Phoenix Arizona 85020
University Clinical Research, Inc. Pembroke Pines Florida 33024
Advanced Clinical Research Meridian Idaho 83642
Accelovance South Bend Indiana 46601
Heartland Research Associates LLC Wichita Kansas 67205
Heartland Research Associates, LLC Wichita Kansas 67207
Kentucky Pediatric /Adult Research Bardstown Kentucky 40004
University of Louisville Louisville Kentucky 40202
Center for Pharmaceutical Research Kansas City Missouri 64114
Radiant Research - St. Louis St Louis Missouri 63141
University of Rochester Medical Center Rochester New York 14642
PMG Research of Raleigh, LLC Cary North Carolina 275188
PMG Research of Raleigh, LLC Raleigh North Carolina 27609
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229
Primary Physicians Research Pittsburgh Pennsylvania 15205
Primary Physicians Research Upper Saint Clair Pennsylvania 15241
Omega Medical Research Warwick Rhode Island 02886
Internal Medicine and Pediatrics Associates of Bristol, PC Bristol Tennessee 37520
PMG Research of Bristoll, LLC Bristol Tennessee 37620
J. Lewis Research Inc./Foothill Family Clinic South Salt Lake City Utah 84109
J. Lewis Research Inc./Foothill Family Clinic South Salt Lake City Utah 84121
Advanced Clinical Research West Jordan Utah 84088
J. Lewis Research/First Med West Jordan Utah 84088
Group Health Research Institute Seattle Washington 98101

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00427895, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 14, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00427895 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →